BR0307754A - R-(-)-1-[2-(7-clorobenzo[b]tiofen-3-il-metóxi)-2-(2,4-diclo rofenil)-etil]-1h-imidazol - Google Patents

R-(-)-1-[2-(7-clorobenzo[b]tiofen-3-il-metóxi)-2-(2,4-diclo rofenil)-etil]-1h-imidazol

Info

Publication number
BR0307754A
BR0307754A BR0307754-3A BR0307754A BR0307754A BR 0307754 A BR0307754 A BR 0307754A BR 0307754 A BR0307754 A BR 0307754A BR 0307754 A BR0307754 A BR 0307754A
Authority
BR
Brazil
Prior art keywords
thiophen
imidazole
ethyl
chlorobenzo
ylmethoxy
Prior art date
Application number
BR0307754-3A
Other languages
English (en)
Inventor
Rafael Foguet
Jorge Ramentol
Antonio Guglietta
Celia Palacin
Luis Anglada
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of BR0307754A publication Critical patent/BR0307754A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

"R-(-)-1-[2-(7-CLOROBENZO[b]TIOFEN-3-IL-METóXI)-2-(2,4-DICL OROFENIL)-ETILI-1H-IMIDAZOL". A presente invenção refere-se a R-(-)-1-[2-(7-cloro-benzo[b]tiofen-3-il-metóxi)-2-(2,4-dicloro-feni)-etil]-1 H-imidazol e aos sais do mesmo. A presente invenção também refere-se a composições do mesmo e seu uso para tratar infecções fúngicas em seres humanos e animais ou combater doenças de plantações. Um processo para sua preparação é também descrito.
BR0307754-3A 2002-02-11 2003-02-04 R-(-)-1-[2-(7-clorobenzo[b]tiofen-3-il-metóxi)-2-(2,4-diclo rofenil)-etil]-1h-imidazol BR0307754A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200200328A ES2203316B1 (es) 2002-02-11 2002-02-11 R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.
PCT/EP2003/001089 WO2003068770A1 (en) 2002-02-11 2003-02-04 R- (-) -1- [2- (7-CHLOROBENZO [b] THIOPHEN-3 -YL- METHOXY) -2- (2,4-DICHLOROPHENYL) -ETHYL] -1H-IMIDAZOLE

Publications (1)

Publication Number Publication Date
BR0307754A true BR0307754A (pt) 2004-12-07

Family

ID=27675919

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307754-3A BR0307754A (pt) 2002-02-11 2003-02-04 R-(-)-1-[2-(7-clorobenzo[b]tiofen-3-il-metóxi)-2-(2,4-diclo rofenil)-etil]-1h-imidazol

Country Status (25)

Country Link
US (1) US7323433B2 (pt)
EP (1) EP1474422B1 (pt)
JP (1) JP5095070B2 (pt)
KR (1) KR100701457B1 (pt)
CN (1) CN1315824C (pt)
AT (1) ATE382618T1 (pt)
AU (1) AU2003205733B8 (pt)
BR (1) BR0307754A (pt)
CA (1) CA2474627C (pt)
CO (1) CO5601026A2 (pt)
DE (1) DE60318395T2 (pt)
DK (1) DK1474422T3 (pt)
ES (1) ES2203316B1 (pt)
HK (1) HK1070883A1 (pt)
IL (1) IL163452A (pt)
MX (1) MXPA04007581A (pt)
NO (1) NO327937B1 (pt)
NZ (1) NZ534464A (pt)
PL (1) PL211168B1 (pt)
PT (1) PT1474422E (pt)
RU (1) RU2276152C1 (pt)
TN (1) TNSN04140A1 (pt)
UA (1) UA78010C2 (pt)
WO (1) WO2003068770A1 (pt)
ZA (1) ZA200405941B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2249992B1 (es) * 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Un procedimiento para fabricar compuestos enantiomericos del imidazol.
ES2249991B1 (es) * 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Procedimiento de fabricacion de compuestos imidazolicos, sus sales y sus pseudopolimorfos.
EP1698336A1 (en) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
AU2009326091A1 (en) * 2008-12-09 2010-06-17 Ferrer Internacional, S.A. Polymorph II of an antifungal compound
EP2436374A1 (en) * 2010-09-30 2012-04-04 Ferrer Internacional, S.A. Ovule for vaginal administration of arasertaconazole
EP2551351A1 (en) 2011-07-29 2013-01-30 Interquim, S.A. Process for production of optically active (R)-(-)-1-(2,4-dichloro-phenyl)-2-imidazole-1-yl-ethanol
CN102440947B (zh) * 2011-11-15 2012-12-26 海南海神同洲制药有限公司 硝酸舍他康唑乳膏剂
KR101717968B1 (ko) 2016-07-18 2017-03-20 씨앤아이 주식회사 스마트폰 결합 모듈
CN113480517B (zh) * 2021-07-30 2022-09-09 海南海神同洲制药有限公司 3-溴甲基-7-氯苯并[b]噻吩的合成方法
CN113735843B (zh) * 2021-09-07 2023-05-26 海南海神同洲制药有限公司 一种低熔点硝酸舍他康唑的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
CA1250586A (en) * 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
NZ278402A (en) * 1995-01-04 1997-10-24 Ferrer Int Polymorphs of sertaconazole mononitrate (ie 1-[2,4-dichloro-beta-[(7-chlorobenzo[b]thien-3-yl)methoxy]phen ethyl]imidazole mononitrate)

Also Published As

Publication number Publication date
JP5095070B2 (ja) 2012-12-12
PL370251A1 (en) 2005-05-16
AU2003205733B2 (en) 2008-08-14
CN1315824C (zh) 2007-05-16
ES2203316A1 (es) 2004-04-01
KR20040079996A (ko) 2004-09-16
ZA200405941B (en) 2006-07-26
IL163452A (en) 2011-11-30
NZ534464A (en) 2006-02-24
ATE382618T1 (de) 2008-01-15
KR100701457B1 (ko) 2007-03-29
DE60318395D1 (de) 2008-02-14
CA2474627C (en) 2009-09-22
AU2003205733A1 (en) 2003-09-04
US7323433B2 (en) 2008-01-29
WO2003068770A1 (en) 2003-08-21
ES2203316B1 (es) 2005-03-01
RU2004127573A (ru) 2006-02-10
PT1474422E (pt) 2008-02-28
RU2276152C1 (ru) 2006-05-10
CN1630654A (zh) 2005-06-22
UA78010C2 (uk) 2007-02-15
TNSN04140A1 (en) 2007-03-12
DK1474422T3 (da) 2008-05-13
EP1474422A1 (en) 2004-11-10
AU2003205733B8 (en) 2008-09-04
CO5601026A2 (es) 2006-01-31
JP2005524639A (ja) 2005-08-18
PL211168B1 (pl) 2012-04-30
NO20043377L (no) 2004-08-13
US20050065201A1 (en) 2005-03-24
HK1070883A1 (en) 2005-06-30
DE60318395T2 (de) 2009-01-02
CA2474627A1 (en) 2003-08-21
MXPA04007581A (es) 2004-11-10
NO327937B1 (no) 2009-10-26
EP1474422B1 (en) 2008-01-02

Similar Documents

Publication Publication Date Title
HK1070883A1 (en) R-(-)-1-2-(7-chlorobenzo-b-thiophen-3-yl-methoxy)-2(2,4-dichlorophenyl)ethyl-1h-imidazole
HK1091481A1 (en) Therapeutic agents useful for treating pain
WO2004016086A3 (en) 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
HUP9901550A2 (hu) Növényimmunizáló hatású benzotiadiazolszármazékot tartalmazó szinergetikus fungicid készítmények és alkalmazásuk
PT884997E (pt) Composicoes contendo um fungicida e um composto sulfurado
BR0209430A (pt) Compostos heterocìclicos
EA200100586A1 (ru) Применение производных фосфономуравьиной кислоты для лечения инфекций
DE69727948D1 (de) Sordarinderivate
WO2000016757A8 (de) Verwendung von phosphororganischen verbindungen zur herstellung von arzneimitteln zur therapeutischen und prophylaktischen behandlung von infektionen oder als fungizid, bakterizid oder herbizid bei pflanzen
WO2002055022A3 (en) Active metabolite of antifungal compound
WO2003007878A3 (en) Antifungal agents of sordarin derivatives
BG104259A (en) Derivatives of 4-cyano-4-deformylsordaricin
AR026545A1 (es) Combinaciones de productos activos fungicidas
EA200100585A1 (ru) Применение производных фосфономуравьиной кислоты для лечения инфекций
DE69815355D1 (de) 4-cyano-4-deformylsordarinderivate
ES2195918T3 (es) Combinaciones de productos activos fungicidas.
CR7413A (es) R-(-)-1-[2-(7-Chlorobenzo[b]thiophen-3-yl-methozy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole
BR0214651A (pt) Compostos, processo para prepará-los, uso dos mesmos, método para controlar fungos fitopatogênicos em safras agrìcolas, composições fungicidas, e, uso das composições fungicidas
MXPA05013760A (es) Composicion y procedimiento de tratamiento del platanero y del bananero.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2447 DE 28-11-2017 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.